Metoprolol for anxiety
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol for Anxiety: Efficacy and Considerations
Introduction to Metoprolol and Anxiety
Metoprolol, a selective beta-1 adrenoceptor antagonist, has been explored for its potential benefits in managing anxiety disorders. Unlike non-selective beta-blockers like propranolol, metoprolol targets beta-1 receptors primarily in the heart, which may result in fewer side effects and make it a suitable option for patients with respiratory issues.
Efficacy of Metoprolol in Anxiety Disorders
Clinical Studies and Anxiety Reduction
Several studies have demonstrated the efficacy of metoprolol in reducing anxiety symptoms. A pilot study indicated that metoprolol effectively reduced heart rate and systolic blood pressure in response to mental stress, suggesting its potential in managing anxiety neurosis. Another study involving 15 patients with moderate to severe anxiety showed significant improvement in anxiety symptoms over a 6-week period, particularly in somatic symptoms, with minimal side effects.
Pre-operative Anxiety Management
Metoprolol has also been evaluated for its effects on pre-operative anxiety. In a double-blind study of patients undergoing elective hysterectomy, those who received metoprolol reported significantly lower anxiety levels compared to the placebo group. Another study with a larger sample size confirmed these findings, showing that patients premedicated with metoprolol were less anxious and better sedated before surgery.
Metoprolol in Special Populations
Elderly Patients
While metoprolol is generally well-tolerated, there are reports of neuropsychiatric adverse reactions in elderly patients. An 81-year-old patient developed sleep disorders, nightmares, depression, and anxiety as probable side effects of low-dose metoprolol, highlighting the need for careful monitoring in this population.
Bereavement and Cardiovascular Risk
In a study of recently bereaved individuals, metoprolol combined with aspirin was found to reduce anxiety and other cardiovascular risk markers without adversely affecting the intensity of bereavement. This suggests a potential preventive benefit of metoprolol during periods of heightened cardiovascular risk associated with early bereavement.
Chronic Heart Failure Patients
For patients with chronic heart failure (CHF) and concurrent anxiety, metoprolol has shown anxiolytic benefits. However, it may worsen depressive and burnout symptoms, indicating that physicians should be cautious when prescribing metoprolol to CHF patients with mental disorders.
Conclusion
Metoprolol appears to be an effective option for managing anxiety, particularly in reducing somatic symptoms and pre-operative anxiety. However, its use in elderly patients and those with chronic heart failure requires careful consideration due to potential adverse effects. Further research is needed to fully understand the benefits and limitations of metoprolol in various patient populations.
Sources and full results
Most relevant research papers on this topic